Wed, Mar 4, 2015, 3:53 PM EST - U.S. Markets close in 7 mins.

Recent

% | $
Quotes you view appear here for quick access.

Sanofi Message Board

gettinricher 50 posts  |  Last Activity: Mar 3, 2015 1:35 PM Member since: Apr 26, 1999
  • gettinricher gettinricher Jan 31, 2015 11:13 AM Flag

    He's obviously got mental issues, so just let him talk back and forth with himself, cause like you said, he's only embarassing himself. Poor fellow.

  • gettinricher gettinricher Jan 29, 2015 9:57 AM Flag

    Hope to hear some updates on a few of their deals going on, but,don't know if they can or will say to much yet, but I hope they atleast give us a little taste of what's to come. Conf., call on tuesday. I'll be there. GLTAL's.

    Sentiment: Strong Buy

  • gettinricher gettinricher Jan 26, 2015 9:41 AM Flag

    Way to conservative.

    Sentiment: Strong Buy

  • Reply to

    Great new on PACB 2015 Roadmap

    by maitrikaruna Jan 22, 2015 12:01 PM
    gettinricher gettinricher Jan 22, 2015 4:56 PM Flag

    Good information. Thanks, had not yet seen this. Looking forward to conference call, and hopefully, maybe an update on the new diagnostic equip., but not holding my breath, but it is coming soon. GLTAL's.

    Sentiment: Strong Buy

  • Been waiting for the pullback after the recent run, and I thought that baring any major market melt down that this would be a great entry point to jump onboard this stock. Don't know if we might go down a little more or if I bought in at the new bottom since the news, but I'm not worried at all about this one headed much higher. GLTAL's

    Sentiment: Strong Buy

  • Reply to

    Sell Trading this Morning

    by amacfar641 Jan 21, 2015 12:32 PM
    gettinricher gettinricher Jan 22, 2015 9:28 AM Flag

    It's called manipulation. Drive it down then buy it back before the suckers that sold know what hit them. In my opinion, if you are stupid enough to panic sell into this kind of game, then you deserve to take the losses. This is a strong time of year for tankers, and with oil where it's at, we should be trading much higher in the coming weeks and months. GLTAL's.

    Sentiment: Strong Buy

  • Best long read out there, and cost competitive with short read companies. Large amount of new interest in their tech.

    Sentiment: Strong Buy

  • gettinricher gettinricher Jan 14, 2015 10:18 AM Flag

    Yes, they are presenting today.

    Sentiment: Strong Buy

  • Reply to

    Genome conference

    by gettinricher Jan 12, 2015 9:38 AM
    gettinricher gettinricher Jan 13, 2015 10:11 AM Flag

    Must have liked what they heard at the Genome conference. Lets see what the JP Morgan Healthcare conference does for them. So far so good, but I think this is still the buzz from what went on at the Genome conf., as there we're many of their users talking directly on the results from using their technology.

    Sentiment: Strong Buy

  • gettinricher by gettinricher Jan 12, 2015 9:38 AM Flag

    If this little bump up is a result of the genome conference, then it should follow through into this week as they present at the JP Morgan Healthcare conference starting today

    Sentiment: Strong Buy

  • gettinricher by gettinricher Jan 11, 2015 8:32 AM Flag

    Big money coming in. Should see more accumulation this week, as they are presenting now at the 23rd plant and animal genome conference, followed up Jan 12th - 15th at the JP Morgan Healthcare Conference. They are really starting to get a following. Should be a great year for PACB.

    Sentiment: Strong Buy

  • Reply to

    Dividend due around Jan 20th

    by dgoose55 Dec 23, 2014 10:09 AM
    gettinricher gettinricher Jan 7, 2015 4:04 PM Flag

    It's finally getting it's legs, and she's ready to run. Looks like maybe she won't make a liar out of me after all. GLTAL's.

    Sentiment: Strong Buy

  • http://www.stockta.com/cgi-bin/analysis.pl?symb=NAT&cobrand=&mode=stock. And closing just a few pennies from HOD, also bullish. GLTAL's

    Sentiment: Strong Buy

  • Reply to

    News out!

    by gettinricher Jan 5, 2015 8:00 AM
    gettinricher gettinricher Jan 6, 2015 7:02 PM Flag

    Even thought this isn't really news, I think between this conference and the JP Morgan 33rd annual Healthcare conf. that they will be at on Jan. 12-15th. it should garner alot of interest.

    Sentiment: Strong Buy

  • Reply to

    Gartman on Fast Money

    by bqdoo Jan 5, 2015 9:44 PM
    gettinricher gettinricher Jan 6, 2015 9:51 AM Flag

    I said in a post weeks ago that I personally thought we would get to $12.00 quickly, and end the winter season at $15.00 or higher,especially with rates where they are. But, for some reason we haven't jumped as quickly as I thought we would. In my opinion we should already be sitting at $12.00 on our way to $15.00. Maybe when they announce the divy on the (the 9th we will get a liittle more of a pop.

    Sentiment: Strong Buy

  • Any day now I would excpect new of the cancer treatment results. Very optimistic on what this data says.

    Sentiment: Strong Buy

  • Reply to

    News out!

    by gettinricher Jan 5, 2015 8:00 AM
    gettinricher gettinricher Jan 5, 2015 8:05 AM Flag

    Looks like more and more are using SMRT Sequencing tech. Unbelievable how much interest has grown in just the past year. Really looking forward to what the new equipment will be like. In my opinion, they could take over Illumina's spot in this field no problem.

    Sentiment: Strong Buy

  • gettinricher by gettinricher Jan 5, 2015 8:00 AM Flag

    Pacific Biosciences Customers Present Work on Complex De Novo Genomes and Genome Annotation at the International Plant & Animal Genome XXIII Conference
    GlobeNewswire22 minutes ago
    Companies mentioned
    PACB
    $7.81 USD$0.00(0.00%)

    Add to watchlist | Set alert | Trade
    You currently hold Pacific Biosciences of California Inc
    MENLO PARK, Calif., Jan. 5, 2015 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System, today announced its participation in the International Plant & Animal Genome (PAG) XXIII Conference taking place in San Diego from January 10-14. More than 50 researchers from around the world will be presenting their work, many representing large consortium efforts, using Single Molecule, Real-Time (SMRT®) Sequencing to assemble de novo and/or analyze complex genomes from a variety of plants and animals.
    The company will hold a workshop on January 13 from 1:30-3:30 p.m. where current PacBio customers from the Arabica Coffee Genome Consortium, Keygene and the USDA will present SMRT Sequencing results on their genome projects for coffee, cotton, and goat, respectively. The winner of last year's "The Most Interesting Genome in the World" grant program, Dr. Robert VanBuren from Donald Danforth Plant Science Center, will also present his data on the Oropeitum thomaeum (Oro) genome, a grass that can tolerate extreme desiccation and regrow once water is again available and which could provide important insights into mechanisms that can potentially improve drought resistance in crops.
    "The Most Interesting Genome in the World" grant program will again be held at this year's conference, providing the opportunity for researchers to submit their proposal to have their genome of interest sequenced on the PacBio RS II. Co-sponsors of the program include Sage Science, Computomics, and the Arizona Genomics Institute. More details are available at: www.pacb.com/smrtgrant.
    Companies in the news
    PACB
    Pacific Biosciences of California Inc
    $7.81
    0.00%
    As of 7:51a ET 1/5/2015. Quotes are delayed by at least 15 minutes.
    "Overall, we have seen tremendous progress from researchers working with larger, more complex genomes in the plant and animal space and are pleased to see more than 50 presentations using SMRT Sequencing on the agenda." said Kevin Corcoran, Senior Vice President, Market Development for Pacific Biosciences. "Since last year's PAG meeting, many more customers have taken advantage of our Iso-Seq™ application for full-length transcript sequencing and together we are looking forward to sharing more about the advantages of this approach for discovering novel genes and gene isoforms."
    About the PacBio RS II and SMRT Sequencing
    Pacific Biosciences' SMRT Sequencing technology achieves the industry's longest read lengths, highest consensus accuracy, and the least degree of bias. These characteristics, combined with the ability to detect many types of DNA base modifications (e.g., methylation) as part of the sequencing process, make the PacBio RS II an essential tool for many scientists studying genetic and genomic variation. The PacBio platform provides a sequencing solution that can address a growing number of complex medical, agricultural, and industrial problems.
    About Pacific Biosciences
    Pacific Biosciences of California, Inc. (Nasdaq:PACB) offers the PacBio RS II DNA Sequencing System to help scientists solve genetically complex problems. Based on its novel Single Molecule, Real-Time (SMRT) technology, the company's products enable: targeted sequencing to more comprehensively characterize genetic variations; de novo genome assembly to more fully identify, annotate, and decipher genomic structures; and DNA base modification identification to help characterize epigenetic regulation and DNA damage. By providing access to information that was previously inaccessible, Pacific Biosciences enables scientists to increase their understanding of biological systems. More information is available at www.pacb.com
    CONTACT: Media:
    Nicole Litchfield
    415.793.6468
    nicole@bioscribe.com

    Investors:
    Trevin Rard
    650.521.8450
    ir@pacificbiosciences.com

    Sentiment: Strong Buy

  • gettinricher gettinricher Jan 3, 2015 9:32 AM Flag

    Almost touched the 52 week high intraday just a few days back. Very bullish. Very nice accumulation going on lately, especially since it's usually end of year tax selling going on in most other stocks. Also very bullish. Wondering if we see another milestone payment yet this quarter, and wondering also how long we will have to wait to see the new euipment unvailed. I also hold this one long term. This stock has alot of room to run,that is if we don't get taken out. All you need to do is look at who's who on the board, and especially the last couple added. I still don't get why they almost seem to hide the fact that they are going to the big conferences, like the upcoming JP Morgan 33rd annual Healthcare conf., that they will be attending Jan. 12-15th. It isn't shown on their main webpage like the others, you have to jump around under events and presentations to find this out. Almost like they don't want it to be known. I'm sure they have a good reason, because they have a great mgt.team in place. Anyway I hope to be hearing news in the near future. GLTAL's, and Happy New Year.

    Sentiment: Strong Buy

  • Reply to

    Zac's Theme

    by herbwellis Dec 20, 2014 4:59 PM
    gettinricher gettinricher Dec 26, 2014 11:02 AM Flag

    He really is disturbed. What kind of life he must have. So sad.

    Sentiment: Strong Buy

SNY
48.15+0.07(+0.15%)3:52 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.